A “highly pathogenic avian flu” has been detected in Japan, which is euthanizing thousands of chickens after an outbreak at a poultry farm.

About 143,000 egg-laying chickens are being exterminated at the farm in Yokote city in Akita Prefecture, the ministry said in a statement on its website, adding that restricted zones up to 10 kms (6.2 miles) from the site have been established.

Japan has temporarily suspended exports of chicken meat and eggs from all regions following the outbreak, the ministry said.

“Under the current situation in Japan, we do not believe that there is any possibility of avian influenza being transmitted to humans through the consumption of chicken meat or eggs,” the ministry said.

Get the full story at reuters.com

avian flu japan

Go To Source For Respiratory Therapy Coverage

RT delivers in-depth coverage of the clinical, regulatory, and technology landscape for respiratory therapy—and reaches more than 28,000 key decision-makers and influencers. As one of healthcare’s most important data companies, we facilitate the rapid adoption of medical devices and practice management tools into the industry.

Go To Source For Respiratory Therapy Coverage RT delivers in-depth coverage of the clinical, regulatory, and technology landscape for respiratory therapy—and reaches more than 28,000 key decision-makers and influencers. As one of healthcare’s most important data companies, we facilitate the rapid adoption of medical devices and practice management tools into the industry. Go To Source For Respiratory Therapy Coverage RT delivers in-depth coverage of the clinical, regulatory, and technology landscape for respiratory therapy—and reaches more than 28,000 key decision-makers and influencers. As one of healthcare’s most important data companies, we facilitate the rapid adoption of medical devices and practice management tools into the industry. Go To Source For Respiratory Therapy Coverage RT delivers in-depth coverage of the clinical, regulatory, and technology landscape for respiratory therapy—and reaches more than 28,000 key decision-makers and influencers. As one of healthcare’s most important data companies, we facilitate the rapid adoption of medical devices and practice management tools into the industry.